{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Toronto",
      "state": "N/A",
      "country": "Canada",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "75984",
      "recalling_firm": "Apotex Inc.",
      "address_1": "150 Signet Drive",
      "address_2": "N/A",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0471-2017",
      "product_description": "Aripiprazole Tablets, 2 mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9; Manufactured for: Apotex Corp., Weston, Florida  33326, NDC 60505-3075-3.",
      "product_quantity": "67,946 bottles",
      "reason_for_recall": "Superpotent Drug: Product may not meet specifications throughout shelf life.",
      "recall_initiation_date": "20161219",
      "center_classification_date": "20170209",
      "termination_date": "20220615",
      "report_date": "20170215",
      "code_info": "Lot #: MJ7746, Exp 04/17"
    }
  ]
}